Sergey Yurasov
2023
In 2023, Sergey Yurasov earned a total compensation of $1.2M as Chief Medical Officer at Black Diamond Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $205,065 |
|---|---|
| Option Awards | $514,760 |
| Salary | $488,250 |
| Other | $25,609 |
| Total | $1,233,684 |
Yurasov received $514.8K in option awards, accounting for 42% of the total pay in 2023.
Yurasov also received $205.1K in non-equity incentive plan, $488.3K in salary and $25.6K in other compensation.
Rankings
In 2023, Sergey Yurasov's compensation ranked 992nd out of 3,006 executives tracked by ExecPay. In other words, Yurasov earned more than 67.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 992 out of 3,006 | 67th |
Division Manufacturing | 591 out of 1,650 | 64th |
Major group Chemicals And Allied Products | 405 out of 918 | 56th |
Industry group Drugs | 394 out of 881 | 55th |
Industry Biological Products, Except Diagnostic Substances | 121 out of 213 | 43rd |
Source: SEC filing on April 24, 2024.
Yurasov's colleagues
We found three more compensation records of executives who worked with Sergey Yurasov at Black Diamond Therapeutics in 2023.